Home Exhibits Exhibit Search

SEDDS Self-Emulsifying Drug Delivery System

Back

SEDDS Self-Emulsifying Drug Delivery System

Self-emulsifying drug delivery systems (SEDDS) are a technology used to enhance the oral bioavailability of poorly soluble drugs. They are isotropic mixtures of oils, surfactants, and sometimes cosolvents, which spontaneously form fine oil-in-water emulsions or microemulsions when exposed to aqueous environments like those in the gastrointestinal tract. This emulsification increases the solubility and absorption of the drug, improving its bioavailability.

Gattefossé

With our vision of improving whole level of local cosmetic industries, we are enthusiastic to introduce the best trendy product and the latest technology to China & Taiwan. ELGIN's headquarter is located in Taipei city, with other two sales office in Taichung and Tainan in order to providing closer service to customer in central and south Taiwan. An application laboratory is built up with professional specialists with decades-experience. To provide our customer comprehensive technical support. In order to provide best products on the right time, our independent warehouse was set in Chia-Yi to guarantee that all delivery will be efficient and under quality control and stock management. Since 1992, ELGIN started to expand business to China, from South to North, total of five sales offices, two application laboratory and three warehouses were established for supporting all personal care manufacturers in China. Our China headquarter is located in Shanghai.

Contact

  • Name:Cindy Chen

  • Phone:02-8751-6060*2065

  • Address:-

Email

Other Information

  • Pavilion:Sustainability International Exhibitors GI09

  • Affiliated Ministry:Ministry of Agriculture

  • Application Field:Agriculture

Location More info

Patent

  • US 6 054136

    • Patent Name
    • Application Country
    • Patent type
    • Assignee
    • Application Number
    • Publish Number
    • Patent Name

      Orally administrable composition capable of providing enhanced bioavailability when ingested

    • Application Country

      United States of America、USA

    • Patent type

      Utility Invention

    • Assignee

      Gattefossé S.A.

    • Application Number

      US 6 054136

    • Publish Number

      US 6 054136

Website & Links

  • Technology maturity:Mass production

  • Exhibiting purpose:Technology transactions

  • Trading preferences:Technical license/cooperation

Inquiry

*Organization

*Name

*Email

*Request & Comments

Request Specifications

Meeting & Discussion

*Organization

*Name

*Email

*Phone

*Main Purpose

*Discuss Further




*Job Category







*Overall Rating

*Favorite Area

*Key Tech Focus

*Willing to Receive Updates?


Other Suggestions

Coming soon!

TOP

Login

Account

Password